Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: TNS007
MIFTS: 46

Taeniasis

Categories: Infectious diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Taeniasis

About this section

MalaCards integrated aliases for Taeniasis:

Name: Taeniasis 12 73 15 17 32
Infection by Taeniarhynchus Saginatus 12
Taenia Saginata Infectious Disease 12
Taenia Saginata Infection 70
Beef Tapeworm Infection 12

Classifications:

MalaCards categories:
Global: Infectious diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:0050596
ICD9CM 34 123.2
SNOMED-CT 67 69163003
ICD10 32 B68 B68.1 B68.9
UMLS 70 C0152073
Sources

Summaries for Taeniasis

About this section
Disease Ontology : 12 A parasitic helminthiasis infectious disease that has material basis in Taenia solium or has material basis in Taenia saginata, which are transmitted by ingestion of undercooked contaminated meat.

MalaCards based summary : Taeniasis, also known as infection by taeniarhynchus saginatus, is related to cysticercosis and enterobiasis. An important gene associated with Taeniasis is MT-CO1 (Mitochondrially Encoded Cytochrome C Oxidase I), and among its related pathways/superpathways are TGF-Beta Pathway and Akt Signaling. The drugs Praziquantel and tannic acid have been mentioned in the context of this disorder. Affiliated tissues include lung, skin and bone, and related phenotypes are digestive/alimentary and respiratory system

Wikipedia : 73 Taeniasis is an infection within the intestines by adult tapeworms belonging to the genus Taenia. There... more...

Sources

Related Diseases for Taeniasis

About this section

Diseases related to Taeniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 635)
# Related Disease Score Top Affiliating Genes
1 cysticercosis 31.5 TXNRD3 MT-ND1 MT-CO1 IL6 IL5 IL4
2 enterobiasis 31.0 TES MT-CO1 IL4
3 hymenolepiasis 30.9 TES MT-CO1
4 ascaris lumbricoides infection 30.7 IL6 IL5 IL13
5 ancylostomiasis 30.5 TES MT-CO1
6 giardiasis 30.4 IL10 CD8A CD4
7 trichinosis 30.3 IL5 IL4 IL13 IL10 CD4
8 diphyllobothriasis 30.3 MT-ND1 MT-CO1
9 hypereosinophilic syndrome 30.2 IL5 IL4 IL2 IL13 IL10
10 trichuriasis 30.0 TNF IL13 IL10
11 appendicitis 30.0 TNF IL6 IL2 IL10
12 amebiasis 29.9 TNF IL4 IL10 CD4
13 fascioliasis 29.9 TXNRD3 MT-ND1 MT-CO1 IL10 CTSL
14 ileus 29.9 TNF IL6 IL10
15 severe combined immunodeficiency 29.9 IL6 IL4 IL2 IL13 IL10
16 schistosomiasis 29.9 TNF IL5 IL4 IL2 IL13 IL10
17 obstructive jaundice 29.8 TNF IL6 IL2
18 paragonimiasis 29.8 TES MT-CO1 IL5 IL13 CTSL
19 intestinal obstruction 29.7 TNF IL6 CD8A
20 clonorchiasis 29.7 TNF MT-CO1 IL2 IL10 CTSL
21 chagas disease 29.7 TNF IL6 IL4 IL2 IL10 CD4
22 echinococcosis 29.7 TNF MT-ND1 MT-CO1 IL6 IL5 IL10
23 strongyloidiasis 29.6 TES MT-CO1 IL5 IL4 IL13 CD4
24 filariasis 29.6 TNF IL6 IL5 IL2 IL10
25 diarrhea 29.6 TNF IL6 IL5 IL2 IL13 IL10
26 salmonellosis 29.5 TNF IL6 IL10 CD8A CD4
27 cystic echinococcosis 29.5 MT-ND1 MT-CO1 IL6 IL10 CES2 CES1
28 deficiency anemia 29.4 TNF MT-CYB IL6 CD8A CD4
29 leishmaniasis 29.2 TNF IL6 IL5 IL4 IL2 IL13
30 allergic disease 29.2 TNF IL6 IL5 IL4 IL2 IL13
31 disease by infectious agent 29.1 TNF IL6 IL4 IL2 IL10 CD8A
32 parasitic helminthiasis infectious disease 27.7 TXNRD3 TNF TES MT-ND1 MT-CO1 IL6
33 1-chloro-2,4-dinitrobenzene allergic contact dermatitis 10.4 IL4 IL2
34 cytokine deficiency 10.4 IL5 IL13
35 cystoisosporiasis 10.4 MT-CO1 CD4
36 coenurosis 10.4 MT-ND1 MT-CO1
37 acute asthma 10.4 IL5 IL4
38 cefaclor allergy 10.4 IL5 IL13
39 virus associated hemophagocytic syndrome 10.4 IL4 IL2
40 punctate inner choroidopathy 10.4 TNF IL10
41 oesophagostomiasis 10.4 MT-CYB MT-CO1
42 cefuroxime allergy 10.4 IL5 IL13
43 cow milk allergy 10.3 IL5 IL4 IL10
44 gnathomiasis 10.3 TES MT-CO1
45 acute transverse myelitis 10.3 IL6 IL10
46 respiratory syncytial virus infectious disease 10.3 IL5 IL13
47 multifocal choroiditis 10.3 TNF IL10
48 beta-lactam allergy 10.3 IL4 IL13 IL10
49 nut allergy 10.3 IL5 IL4 IL13
50 cork-handlers' disease 10.3 CD8A CD4

Graphical network of the top 20 diseases related to Taeniasis:



Diseases related to Taeniasis
Sources

Symptoms & Phenotypes for Taeniasis

About this section

MGI Mouse Phenotypes related to Taeniasis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.61 CD4 IL10 IL13 IL2 IL4 IL5
2 respiratory system MP:0005388 9.23 IL10 IL13 IL2 IL4 IL5 IL6
Sources

Drugs & Therapeutics for Taeniasis

About this section

Drugs for Taeniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Praziquantel Approved, Investigational, Vet_approved Phase 3 55268-74-1 4891
2
tannic acid Approved Phase 3 1401-55-4
3
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
4
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3 50-02-2 5743
5
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3 1177-87-3
6
Acetazolamide Approved, Vet_approved Phase 2, Phase 3 59-66-5 1986
7 Antacids Phase 3
8 Proton Pump Inhibitors Phase 3
9 Anti-Ulcer Agents Phase 3
10 Antiemetics Phase 2, Phase 3
11 Hormones Phase 2, Phase 3
12 Gastrointestinal Agents Phase 2, Phase 3
13 glucocorticoids Phase 2, Phase 3
14 Hormone Antagonists Phase 2, Phase 3
15 Antineoplastic Agents, Hormonal Phase 2, Phase 3
16 Anticonvulsants Phase 2, Phase 3
17 Anti-Inflammatory Agents Phase 2, Phase 3
18 diuretics Phase 2, Phase 3
19 Carbonic Anhydrase Inhibitors Phase 2, Phase 3
20
Omeprazole Approved, Investigational, Vet_approved Phase 2 73590-58-6 4594
21
Oxfendazole Investigational, Vet_approved Phase 1 53716-50-0 40854
22 Benzimidazole Experimental, Investigational Phase 1 51-17-2
23
Niclosamide Approved, Investigational, Vet_approved 50-65-7 4477
24
Phenytoin Approved, Vet_approved 57-41-0 1775
25 Sodium Channel Blockers
26 Diuretics, Potassium Sparing

Interventional clinical trials:

(show all 23)
# Name Status NCT ID Phase Drugs
1 A Clinical Trial to Study the Effects of Two Different Duration of Same Drug Albendazole in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT Scan Head at the End of 6 Months Completed NCT02243644 Phase 3 7 days of albendazole 15 mg/kg/day;28 days of albendazole 15 mg/kg/day
2 Antiparasitic Therapy for Neurocysticercosis: Phase II/III Study on Safety and Efficacy of Combined Treatment With Praziquantel and Albendazole Completed NCT00441285 Phase 2, Phase 3 Praziquantel;Albendazole;ABZ Placebo;PZQ Placebo
3 A Pilot Study of Neurocysticercosis Treatment Completed NCT00283699 Phase 3 albendazole
4 Treatment of Intraparenchymal Neurocysticercosis: Effect of Increased Dosing of Corticosteroids on Seizure Frequency Completed NCT00290823 Phase 3 Albendazole;Dexamethasone;Omeprazole
5 A Randomized Trial of Combined Albendazole Plus Praziquantel for Subarachnoid Cysticercosis of the Sylvian Fissure or the Basal Cisterns Recruiting NCT02947581 Phase 3 Albendazole and praziquantel;Albendazole and praziquantel placebo
6 Open Controled Randomized Pilot Study on the Use of Acetazolamide and Dexamethasone for the Acute Phase of Perilesional Edema in Calcified Neurocysticercosis Terminated NCT02945527 Phase 2, Phase 3 Acetazolamide;Dexamethasone
7 Randomized, Double Blind Comparison of Two Lenghts of Albendazole Therapy for Subarachnoid Cysticercosis Withdrawn NCT00133458 Phase 3 Albendazole
8 An Open-label Non-randomized Phase IIa Trial to Evaluate Safety of Early Intervention in Asymptomatic Subarachnoid Neurocysticercosis Not yet recruiting NCT03950037 Phase 2 Albendazole
9 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FBR Completed NCT00527579 Phase 1 [F-18]FBR
10 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 Completed NCT00526916 Phase 1 [C-11]PBR28
11 A Randomized, Double-Blind Placebo-Controlled Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole Completed NCT02234570 Phase 1 Oxfendazole
12 The Burden of (Neuro)Cysticercosis Among People Living With HIV Compared With HIV-negative Individuals in the Rural Southern Highlands in Tanzania Unknown status NCT03851419
13 Targeted Screening for Taenia Solium Tapeworms Completed NCT01296958 Niclosamide
14 Free Digital Health Education for Diseases of Public Health Importance (HIV, Tuberculosis and Taenia Solium Cysticercosis/Taeniosis) in Iringa, Tanzania Completed NCT03808597
15 Impact of Community-Led Total Sanitation on the Control of Taenia Solium and Soil Transmitted Helminths in the Eastern Province of Zambia Completed NCT01368354
16 Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis Completed NCT00004403 albendazole;dexamethasone;phenytoin
17 Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis Completed NCT00001912
18 EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso Completed NCT03095339
19 Treatment of Cysticercosis Including Neurocysticercosis With Praziquantel, Albendazole and Other Novel Treatment Modalities Recruiting NCT00001205
20 Establishment and Application of a Taenia Solium Experimental Pig Infection Model and Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of Eastern and Southern Provinces of Zambia Recruiting NCT03874689
21 Characteristics of Patients With Symptomatic Active Neurocysticercosis and Effect of Treatment on Symptoms, Lesions and Quality of Life in Resource-poor Rural Areas of Eastern Africa - TOPANA, a Multi-centre Prospective Cohort Study. Not yet recruiting NCT03834337
22 Clinical, Laboratory and Imaging Features, Treatment Trends and Long Term Outcomes in Patients With Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study Not yet recruiting NCT04706819
23 NACC 002: A Multicenter Prospective Natural History Study of Patients Presenting With Neurocysticercosis in North America Terminated NCT02233855

Search NIH Clinical Center for Taeniasis

Sources

Genetic Tests for Taeniasis

About this section
Sources

Anatomical Context for Taeniasis

About this section

MalaCards organs/tissues related to Taeniasis:

40
Lung, Skin, Bone, Eye, Thymus, Liver, Small Intestine
Sources

Publications for Taeniasis

About this section

Articles related to Taeniasis:

(show top 50) (show all 843)
# Title Authors PMID Year
1
Neurocysticercosis in patients with active epilepsy in the tea garden community of Assam, Northeast India. 61
33795818 2021
2
Prevalence of meat-transmitted Taenia and Trichinella parasites in the Far East countries. 61
33768333 2021
3
Zoonotic Taenia infections with focus on cysticercosis due to Taenia solium in swine and humans. 61
33321377 2021
4
Helminthiases in the People's Republic of China: Status and prospects. 61
32841589 2020
5
Eosinophilic pleural effusion as a manifestation of taeniasis. 61
33344319 2020
6
Swine cysticercosis and associated risk factors in non-technified pig breeding in semi-arid region of Sergipe state, Brazil. 61
33230578 2020
7
Force-of-infection of Taenia solium porcine cysticercosis: a modelling analysis to assess global incidence and prevalence trends. 61
33077748 2020
8
Occurrence of Taenia species in pigs in slaughterhouses in Phu Tho province, northern Vietnam. 61
33050957 2020
9
Loop-Mediated Isothermal Amplification as Point-of-Care Diagnosis for Neglected Parasitic Infections. 61
33126446 2020
10
Hospitalization for Chagas disease, dengue, filariasis, leishmaniasis, schistosomiasis, strongyloidiasis, and Taenia solium taeniasis/cysticercosis, Italy, 2011-2016. 61
32418191 2020
11
Endemicity of Taenia solium cysticercosis in pigs from Mbeya Rural and Mbozi districts, Tanzania. 61
32883326 2020
12
The viewpoint by White and colleagues critiquing the evaluation of the safety and efficacy of mass chemotherapy for Taenia solium taeniasis is unsubstantiated. 61
32881869 2020
13
Impact of a 3-year mass drug administration pilot project for taeniasis control in Madagascar. 61
32946447 2020
14
Epidemiology of Taenia saginata taeniasis with emphasis on its prevalence and transmission in a Kashmiri population in India: A prospective study. 61
32619763 2020
15
Cysticercosis in Madagascar. 61
33031077 2020
16
Seroepidemiological evidence for Taenia solium taeniasis/cysticercosis in three Venezuelan rural communities. 61
32778183 2020
17
Bovine cysticercosis and human taeniasis in a rural community in Ethiopia. 61
32558313 2020
18
The data are inadequate to assess safety and efficacy of mass chemotherapy for Taenia solium taeniasis. 61
32673333 2020
19
Understanding transmission and control of the pork tapeworm with CystiAgent: a spatially explicit agent-based model. 61
32709250 2020
20
Taenia solium Cysticercosis and Its Impact in Neurological Disease. 61
32461308 2020
21
Epidemiology and surveillance of human (neuro)cysticercosis in Europe: is enhanced surveillance required? 61
32083787 2020
22
Host immune responses during Taenia solium Neurocysticercosis infection and treatment. 61
32298263 2020
23
Update on the major imported helminth infections in travelers and migrants. 61
32250168 2020
24
Modelling for Taenia solium control strategies beyond 2020. 61
32132754 2020
25
Consumer knowledge and practices to pork safety in two Taenia solium cysticercosis endemic districts in Eastern Cape Province of South Africa. 61
32028912 2020
26
Epidemiology of Parasitic Infections in the West Bank and Gaza Strip, Palestine. 61
31769396 2020
27
Soil-transmitted helminth infections and taeniasis on Samosir Island, Indonesia. 61
31678236 2020
28
Taenia asiatica: Historical overview of taeniasis and cysticercosis with molecular characterization. 61
32291084 2020
29
Diagnostic Method to Screen Taenia solium Taeniasis Carriers. 61
31914439 2020
30
Control of taeniasis and cysticercosis in China. 61
32563329 2020
31
Cysticercosis, a Potential Public Health Concern in Kuwait: A New Diagnostic Method to Screen Taenia solium Taeniasis Carriers in the Expatriate Population. 61
31698357 2020
32
Reply to the Letter "Diagnostic Method to Screen Taenia solium Taeniasis Carriers". 61
32018246 2020
33
Systematic review of the effectiveness of selected drugs for preventive chemotherapy for Taenia solium taeniasis. 61
31945055 2020
34
Currently Available Monitoring and Surveillance Systems for Taenia spp., Echinococcus spp., Schistosoma spp., and Soil-Transmitted Helminths at the Control/Elimination Stage: A Systematic Review. 61
31935916 2020
35
DNA-Detection Based Diagnostics for Taenia solium Cysticercosis in Porcine. 61
32395335 2020
36
An unexpected finding after robotic subtotal gastrectomy: Vomiting of Taenia Saginata. 61
33083203 2020
37
Development of multi-epitope chimeric vaccine against Taenia solium by exploring its proteome: an in silico approach. 61
31971446 2020
38
Development and application of anthelminthic drugs in China. 61
31542370 2019
39
No Confirmed Cases of Taenia solium Taeniasis in a Group of Recently Arrived Sub-Saharan Migrants to Italy. 61
31847324 2019
40
Taenia solium cysticercosis and taeniasis in urban settings: Epidemiological evidence from a health-center based study among people with epilepsy in Dar es Salaam, Tanzania. 61
31809501 2019
41
High prevalence of taeniasis and Taenia solium cysticercosis in children in western Sichuan, China. 61
31415736 2019
42
A preliminary study to assess the use of a "Snakes and Ladders" board game in improving the knowledge of elementary school children about taeniasis. 61
31369727 2019
43
Seroprevalence of circulating taeniid antigens in pigs and associated risk factors in Kongwa district, Tanzania. 61
31872092 2019
44
Taeniasis and cysticercosis in Asia: A review with emphasis on molecular approaches and local lifestyles. 61
31295430 2019
45
Taeniasis Saginata as Unexpected Cause in the Case of a Woman Scared of Getting Pregnant. 61
32099571 2019
46
Neglected tropical diseases in the People's Republic of China: progress towards elimination. 61
31578147 2019
47
[Taeniasis and enterocystoplasty]. 61
31543395 2019
48
Evaluation of enzyme-linked immunoelectrotransfer blot for diagnosis of cysticercosis in swine from North India. 61
30008272 2019
49
Can We Recommend Practical Interventions to Prevent Neurocysticercosis? 61
31151880 2019
50
Distribution of Taenia solium Diagnostic Glycoproteins in the Different Developmental Stages of the Parasite. 61
31436487 2019
Sources

Variations for Taeniasis

About this section
Sources

Expression for Taeniasis

About this section
Search GEO for disease gene expression data for Taeniasis.
Sources

Pathways for Taeniasis

About this section

Pathways related to Taeniasis according to GeneCards Suite gene sharing:

(show top 50) (show all 53)
# Super pathways Score Top Affiliating Genes
1
TGF-Beta Pathway 63
Show member pathways
 13.55 TNF IL6 IL5 IL4 IL2 IL13
2
Akt Signaling 63
Show member pathways
 13.42 TNF IL6 IL5 IL4 IL2 IL13
3
Cytokine Signaling in Immune system 65
Show member pathways
 13.37 TNF IL6 IL5 IL4 IL2 IL13
4
PAK Pathway 63
Show member pathways
 13.33 TXNRD3 TNF IL6 IL5 IL4 IL2
5
Pathways in cancer 36
12.85 TXNRD3 IL6 IL5 IL4 IL2 IL13
6
Prion disease 36
Show member pathways
 12.83 TNF MT-ND1 MT-CYB MT-CO1 IL6
7
Allograft rejection 36 1
Show member pathways
 12.76 TNF IL6 IL5 IL4 IL2 IL13
8
Immune response NFAT in immune response 23
Show member pathways
 12.65 TNF IL4 IL2 IL10 CD4
9
T cell receptor signaling pathway 36
Show member pathways
 12.62 TNF IL6 IL5 IL4 IL2 IL10
10
Immune response IL-23 signaling pathway 23
Show member pathways
 12.61 TNF IL6 IL2 IL10 CD4
11
Th17 cell differentiation 36
Show member pathways
 12.6 TNF IL6 IL5 IL4 IL2 IL13
12
NF-kappaB Signaling 4
12.59 TNF IL4 IL2 IL10 CD8A
13
JAK-STAT signaling pathway 36
Show member pathways
 12.47 IL6 IL5 IL4 IL2 IL13 IL10
14
Selenium Micronutrient Network 1
Show member pathways
 12.37 TXNRD3 TNF IL6 IL4 IL2
15
IL-17 Family Signaling Pathways 64
Show member pathways
 12.37 TNF IL6 IL5 IL4 IL13
16
Human T-cell leukemia virus 1 infection 36
12.35 TNF IL6 IL2 CD4
17
Chemokine Superfamily Pathway: Human/Mouse Ligand-Receptor Interactions 64
Show member pathways
 12.34 TNF IL6 IL2 IL10
18
Immune response IFN alpha/beta signaling pathway 23
Show member pathways
 12.33 TNF IL6 IL5 IL4 IL2 IL13
19
C-type lectin receptor signaling pathway 36
Show member pathways
 12.23 TNF IL6 IL2 IL10
20
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 1
12.23 TNF TACR1 IL6 IL13 IL10
21
Bacterial infections in CF airways 23
Show member pathways
 12.2 TNF IL6 IL4 CTSL
22
Yersinia infection 36
12.15 TNF IL6 IL2 IL10 CD8A CD4
23
Spinal Cord Injury 1
12.08 TNF TACR1 IL6 IL4 IL2
24
Interleukin-4 and 13 signaling 65
12.05 TNF IL6 IL4 IL13 IL10
25
IL12-mediated signaling events 1
Show member pathways
 12 IL4 IL2 CD8A CD4
26
Hematopoietic cell lineage 36
11.97 TNF IL6 IL5 IL4 CD8A CD4
27
Glucocorticoid receptor regulatory network 1
11.9 IL6 IL5 IL4 IL2 IL13
28
Th1 Differentiation Pathway 64
Show member pathways
 11.85 TNF IL6 IL2 IL10 CD4
29
Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers 64
11.82 TNF IL6 IL5 IL4 IL2 IL10
30
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 1
Show member pathways
 11.81 TNF IL5 IL4 IL2
31
IgA-Producing B Cells in the Intestine 64
11.78 TNF IL6 IL5 IL4 IL10
32
Pertussis 36
11.77 TNF IL6 IL10
33
Dendritic Cells Developmental Lineage Pathway 64
11.75 TNF IL6 IL2 IL10 CD8A CD4
34
Lung fibrosis 1
11.74 TNF IL6 IL5 IL4 IL13
35
Photodynamic therapy-induced NF-kB survival signaling 1
Show member pathways
 11.68 TNF IL6 IL2
36
IL4-mediated signaling events 1
11.67 IL5 IL4 IL10
37
Downstream signaling in naive CD8+ T cells 1
Show member pathways
 11.66 TNF IL2 CD8A
38
Interleukin-10 signaling 65
11.61 TNF IL6 IL4 IL13 IL10
39
Photodynamic therapy-induced AP-1 survival signaling. 1
11.57 TNF IL6 IL2
40
Malaria 36
11.56 TNF IL6 IL10
41
Innate Lymphoid Cell Differentiation Pathways 64
11.46 TNF IL5 IL4 IL2 IL13 IL10
42
African trypanosomiasis 36
11.41 TNF IL6 IL10
43
IL-15 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types 64
Show member pathways
 11.4 TNF IL2 IL10
44
Th2 Differentiation Pathway 64
11.4 IL5 IL4 IL2 IL13 IL10 CD4
45
IL-10 Pathway 63
11.38 TNF IL6 IL10
46
Inflammatory Response Pathway 1
11.35 IL5 IL4 IL2
47
Development and heterogeneity of the ILC family 1
11.34 TNF IL6 IL5 IL4 IL13
48
IL12 signaling mediated by STAT4 1
11.27 IL2 IL13 CD4
49
OX40 Pathway 63
11.18 IL5 IL4 IL2 IL13 IL10
50
G-protein signaling_Rap2B regulation pathway 23
11.06 TNF IL6 IL5 IL4 IL2 IL13
Sources

GO Terms for Taeniasis

About this section

Cellular components related to Taeniasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.32 TNF IL6 IL5 IL4 IL2 IL13
2 respiratory chain GO:0070469 9.13 MT-ND1 MT-CYB MT-CO1

Biological processes related to Taeniasis according to GeneCards Suite gene sharing:

(show all 33)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription, DNA-templated GO:0045893 10.08 TNF IL6 IL5 IL4 IL10 CD4
2 inflammatory response GO:0006954 10 TNF TACR1 IL6 IL5 IL13
3 negative regulation of inflammatory response GO:0050728 9.84 IL4 IL2 IL13 IL10
4 response to glucocorticoid GO:0051384 9.81 TNF IL6 IL10
5 positive regulation of smooth muscle cell proliferation GO:0048661 9.79 TNF IL6 IL13
6 cytokine-mediated signaling pathway GO:0019221 9.76 TNF IL6 IL5 IL4 IL2 IL13
7 T cell activation GO:0042110 9.73 IL4 CD8A CD4
8 positive regulation of DNA-binding transcription factor activity GO:0051091 9.73 TNF IL6 IL5 IL10
9 positive regulation of interleukin-10 production GO:0032733 9.72 IL6 IL4 IL13
10 positive regulation of T cell proliferation GO:0042102 9.71 IL6 IL4 IL2 CD4
11 negative regulation of endothelial cell apoptotic process GO:2000352 9.7 IL4 IL13 IL10
12 positive regulation of B cell proliferation GO:0030890 9.67 IL5 IL4 IL2 IL13
13 positive regulation of podosome assembly GO:0071803 9.66 TNF IL5
14 positive regulation of MHC class II biosynthetic process GO:0045348 9.65 IL4 IL10
15 negative regulation of T-helper 17 cell differentiation GO:2000320 9.65 IL4 IL2
16 positive regulation of isotype switching to IgG isotypes GO:0048304 9.65 IL4 IL2
17 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.65 TNF IL6 IL4 IL2 IL13
18 positive regulation of mast cell degranulation GO:0043306 9.64 IL4 IL13
19 negative regulation of lipid storage GO:0010888 9.64 TNF IL6
20 endothelial cell apoptotic process GO:0072577 9.63 TNF IL10
21 microglial cell activation GO:0001774 9.63 TNF IL4 IL13
22 fusion of virus membrane with host plasma membrane GO:0019064 9.62 CTSL CD4
23 positive regulation of JAK-STAT cascade GO:0046427 9.62 TNF IL6 IL5 IL10
24 vascular endothelial growth factor production GO:0010573 9.61 TNF IL6
25 positive regulation of mononuclear cell migration GO:0071677 9.59 TNF IL4
26 negative regulation of cytokine production involved in immune response GO:0002719 9.58 TNF IL10
27 type 2 immune response GO:0042092 9.58 IL4 IL10
28 electron transport coupled proton transport GO:0015990 9.57 MT-CYB MT-CO1
29 negative regulation of complement-dependent cytotoxicity GO:1903660 9.51 IL4 IL13
30 positive regulation of plasma cell differentiation GO:1900100 9.49 IL2 IL10
31 regulation of isotype switching GO:0045191 9.48 IL4 IL10
32 positive regulation of immunoglobulin production GO:0002639 9.35 IL6 IL5 IL2 IL13 IL10
33 immune response GO:0006955 9.32 TNF IL6 IL5 IL4 IL2 IL13

Molecular functions related to Taeniasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 growth factor activity GO:0008083 9.35 IL6 IL5 IL4 IL2 IL10
2 sterol esterase activity GO:0004771 9.32 CES2 CES1
3 methyl indole-3-acetate esterase activity GO:0080030 9.26 CES2 CES1
4 cytokine activity GO:0005125 9.17 TNF IL6 IL5 IL4 IL2 IL13
5 methylumbelliferyl-acetate deacetylase activity GO:0047374 9.16 CES2 CES1
Sources

Sources for Taeniasis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 20-May-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....